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Background: Senescence in the population of cells is often described as a program of restricted proliferative
capacity, which is manifested by broad morphological and biochemical changes including a metabolic shift
towards an autophagic-like response and a genotoxic-stress related induction of polyploidy. Concomitantly, the cell
cycle progression of a senescent cell is believed to be irreversibly arrested. Recent reports suggest that this
phenomenon may have an influence on the therapeutic outcome of anticancer treatment. The aim of this study
was to verify the possible involvement of this program in the response to the treatment of the A549 cell
population with low doses of etoposide, as well as to describe accompanying cytoskeletal alterations.
Methods: After treatment with etoposide, selected biochemical and morphological parameters were examined,
including: the activity of senescence-associated ß-galactosidase, SAHF formation, cell cycle progression, the
induction of p21Cip1/Waf1/Sdi1 and cyclin D1, DNA strand breaks, the disruption of cell membrane asymmetry/
integrity and ultrastructural alterations. Vimentin and G-actin cytoskeleton was evaluated both cytometrically and
microscopically.
Results and conclusions: Etoposide induced a senescence-like phenotype in the population of A549 cells.
Morphological alterations were nevertheless not directly coupled with other senescence markers including a stable
cell cycle arrest, SAHF formation or p21Cip1/Waf1/Sdi1 induction. Instead, a polyploid, TUNEL-positive fraction of cells
visibly grew in number. Also upregulation of cyclin D1 was observed. Here we present preliminary evidence, based
on microscopic analyses, that suggest a possible role of vimentin in nuclear alterations accompanying
polyploidization-depolyploidization events following genotoxic insults.
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Etoposide is a semi-synthetic derivative of podophyllotoxin
originating from Podophyllum peltatum or Podophyllum
emodi [1]. This compound acts on topoisomerase II, an en-
zyme involved in DNA processing during its replication,
transcription and recombination. A reversible cleavage of
one or both DNA stands by the enzyme is crucial for modu-
lation of its topology, i.e. superhelical structure, as well as
for entangling of the molecule [2]. Etoposide affects cleav-
able enzyme-DNA complexes, by stabilizing them, and thus
inhibiting the ability of topoisomerase to ligate these discon-
tinuities [3]. Interaction of such structures with replication
forks, transcriptional complexes or other DNA-processing
enzymes may finally result in the formation of irreversible
DNA strand breaks [4].
This mode of action is known to be related to the
major chemotherapeutic effect of the agent, i.e. cell
death induction. However, there have also been some
suggestions that the response of cancer cells to etoposide
also involves other mechanisms, such as chromosomal
aberrations, aneuploidy and endoreplication [5,6]. The
significance of these phenomena has not yet been fully
determined and is currently under discussion with re-
gard to mitotic catastrophe, senescence, neosis and cell
survival.
The aim of this paper is to evaluate the influence of
low-dose treatment with etoposide on the A549 cell line
in the context of some cytoskeletal changes related to
the induction of cell death/senescence.
The A549 cell line, which was our experimental
model, has been classified as a non-small cell lung car-
cinoma, adenocarcinoma and was previously derived
from type II pneumocytes [7]. As this type of lung can-
cer is one of the leading causes of death globally, the line
is frequently used in studies investigating the effects of
different drugs. However, before interpretation of the
obtained results, it is crucial to take into consideration
the genetic background of the line, i.e. homozygous
deletions of p16Ink4a, p14Arf and p15Ink4b [8-11]. The
products of these genes influence the outcome of chemo-
therapy, due to their participation in tumor suppression
via cell death/irreversible cell cycle arrest. Therefore it
seems important to evaluate both the possibility and the
extent of induction of these different processes in A549
cells.
Some cytoskeletal components have previously been
shown to be useful as indicators of cell well-being, and
have been described as markers indicative of particular
phenomena [12-15]. In this work, we would like to refer
to selected alterations in the organization as well as the
level of cytoskeletal proteins, especially G-actin and
vimentin, defined as potential markers of cellular senes-
cence, in order to perform a more in-depth analysis of
the characteristics of cellular response to etoposide.Results
Morphological and biochemical features of senescence/
cell death - selected parameters
The influence of etoposide on A549 cells was evaluated
based on the manifestation of particular senescence-
and/or cell death-related events in the cell popula-
tion, including SA ß-galactosidase activity, senescence-
associated heterochromatin foci (SAHF) formation,
p21Cip1/Waf1/Sdi1 and cyclin D1 induction, DNA frag-
mentation rate, as well as the percentage of cells with
phosphatidylserine externalization and/or disruptions
in the cell membrane. Further insight was gained from
transmission electron microscopic observations of the
cell ultrastructure and form flow cytometric analysis of
cell cycle distribution.
The range of doses used in the initial part of this study
was as follows: 0.5; 0.75; 1; 1,5; 2; 3; 6 μM. All these con-
centrations induced a statistically significant increase in
the mean percentage of cells presenting an enhanced ac-
tivity of SA ß-galactosidase as compared to the control
sample (Cochran–Cox statistics; P<0.001) (Figure 1). For
further procedures, however, only those concentrations
were chosen that caused high and significantly different
increases in this activity from one another (Duncan sta-
tistics; P<0.05), i.e. 0.75, 1.5 and 3 μM etoposide.
All the concentrations of etoposide used in this study
(0.75, 1.5, 3 μM) induced a statistically significant de-
crease in the percentage of A549 cells with DNA content
corresponding to G0/G1 and S in comparison to the con-
trol cells (Mann–Whitney U statistics) (Figure 2). Con-
comitantly, there were statistically significant increases
in the population of cells respective to G2/M phases and
higher DNA contents (>G2) (Figure 2). A biparametric
analysis of DNA fragmentation rate in relation to its
content, resulting from the TUNEL method, revealed
that the most significantly damaged fraction was repre-
sented by the cells in G2/M and, particularly, with higher
DNA contents, which was evident at 1.5 and 3 μM eto-
poside (Figure 3).
The highest dose of the drug (3 μM) was most effect-
ive in the induction of DNA strand breaks, which were
present in more than 50% of the cell population
(Figure 4). There were statistically significant increases
in the number of dUTP-FITC-incorporating cells even
after treatment with the lowest of the applied concentra-
tions (0.75 μM) (Figure 5). On the other hand, subG1
fraction, respective to cells with DNA content lower
than typical of G0/G1, was visibly increased only in the
cells exposed to 1.5 and 3 μM etoposide (Figure 2d). As
regards annexin V/PI assay, the results obtained were
similar to TUNEL indications, showing statistically sig-
nificant increases in the percentage of cells manifesting
features of early and late apoptosis, as well as necrosis
after treatment with all etoposide concentrations used in
Figure 1 Activity of senescence-associated ß-galactosidase in A549 cells after treatment with etoposide - statistical data from light
microscopic examinations. Incubation with increasing concentrations of the drug (0.5, 0.75, 1, 1.5, 2, 3 and 6 μM etoposide) for 72 h was
followed by further 24 h of incubation in fresh medium. The activity of the enzyme was detected at pH 6. Very highly statistically significant
differences as compared to the control cells are marked by asterisks (Cochran–Cox statistics, P<0.001). Results are representative of ten
independent experiments.
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Concomitantly, the population of cells with preserved
integrity and asymmetry of membranes was on the de-
crease (Figure 6). At the highest dose of etoposide,
which turned out to be most effective in cell death in-
duction, the following median values were obtained:
2.6% for annexin V-positive/PI-negative cells (features of
early apoptosis), 6.2% for annexin V/PI-positive cellsFigure 2 a-e Cell cycle distribution of A549 cells after treatment with
(staining with RNase/PI). a Cells with DNA content typical of G0/G1 phase
with DNA content typical of G2/M phases, d cells with DNA content typica
Statistically significant differences as compared to the control cells are mar
percentage of cells, bars - interquartile range. Results are representative of(features of late apoptosis/necrosis) and 19% for annexin
V-negative/PI-positive cells (necrotic phenotype).
These biochemical changes were also accompanied by
ultrastructural alterations progressing gradually with in-
creasing concentrations. There were some enlarged cells,
in which not only cytoplasmic, but also nuclear com-
partments were visibly affected. Heterogeneity of the
cytoplasm manifested itself in the appearance ofetoposide - statistical data from flow cytometric analyses
s of the cell cycle, b cells with DNA content typical of S phase, c cells
l of subG1 fraction, e cells with DNA content typical of polyploidy.
ked by asterisks (Mann–Whitney U statistics, P<0.05). Columns - median
five independent experiments.
Figure 3 DNA fragmentation rate in relation to DNA content in A549 cells after treatment with etoposide - representative dot-plots
from flow cytometric analyses (the TUNEL method); upper left - control cells, upper right - 0.75 μM etoposide, lower left - 1.5 μM
etoposide, lower right - 3 μM etoposide.
Figure 4 DNA fragmentation rate in A549 cells after treatment
with etoposide - representative histograms from flow
cytometric analyses (the TUNEL method); upper left - control
cells, upper right - 0.75 μM etoposide, lower left - 1.5 μM
etoposide, lower right - 3 μM etoposide.
Figure 5 DNA fragmentation rate in A549 cells after treatment
with etoposide - statistical data from flow cytometric analyses
(the TUNEL method). Statistically significant differences as
compared to the control cells are marked by asterisks (Mann–
Whitney U statistics, P<0.05). Columns - median percentage of cells,
bars - interquartile range. Results are representative of five
independent experiments.
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Figure 6 a-d Cell viability in the population of A549 cells after
treatment with etoposide - statistical data from flow cytometric
analyses (the annexin V/PI assay). Cells presenting features of
a early apoptosis (annexin V+/PI-), b late apoptosis (annexin V-/PI-),
c necrosis (annexin V-/PI+) and d viable cells (annexin V-/PI-).
Statistically significant differences as compared to the control cells
are marked by asterisks (Mann–Whitney U statistics, P<0.05). Columns
- median percentage of cells, bars - interquartile range. Results are
representative of five independent experiments.
Litwiniec et al. Cancer Cell International 2013, 13:9 Page 5 of 22
http://www.cancerci.com/content/13/1/9electron-dense granular structures, including those mye-
lin-like, and electron-clear vacuole-like components
(Figure 7). Some of these most probably contained resi-
dual materials, while others resembled autophagosomes.
Among other organelles, abundant swollen mitochon-
dria, as well as a few dilated endoplasmic reticulum cis-
ternae were present. Visible morphological changes were
also related to the nucleus area, and they include an
increase in size, chromatin condensations, segmented/
lobulated nuclei, as well as multinucleated cells. Besides
this, some more pronounced signs typical of cell death
may be observed, especially at the highest applied con-
centration, including highly condensed, densely packed
chromatin, extensive cytoplasmic vacuolization, and loss
of easily recognizable forms of organelles, suggesting late
apoptosis or secondary necrosis (Figure 7e,f ). Some cells
representing acute damage manifestations, with degener-
ating cytoplasm, may respond directly by executing ne-
crosis (Figure 7f ). Nevertheless, a subpopulation of cells
did not show significant morphological differences in
comparison with the control group, possibly represent-
ing chemotherapy-resistant clones of A549 cells.
p21Cip1/Waf1/Sdi1 immunolocalization showed neither
significant induction of expression of this protein nor
evident changes in its subcellular localization in the ma-
jority of etoposide-exposed A549 cells (Figure 8). As
opposed to these results, the alterations of localization
and abundance of cyclin D1 were more evident
(Figure 9). As a result of the treatment, some cellsappeared with an increased overall intensity of intranuc-
lear staining for this protein. Besides that, at the higher
concentrations of etoposide (1.5 and 3 μM), the
fluorescence signal was often sequestrated in the form of
foci, especially in the presumptive nucleolar area
(Figure 9e,f ).
Quantification of SAHF and other nuclear abnormal-
ities revealed that the treatment induced profound
changes in nuclear morphology, especially the massive
appearance of the cells with enlarged nuclei (Figure 10
a-e). Although SAHF formation was induced by etopo-
side, the percentage of cells presenting these structures
was maintained at a stable low level independently of
the concentration applied, ranging from 0.45 to 3.99%
after the treatment (Figure 10e). Concomitantly, the
cells with SAFH manifestation revealed neither
p21Cip1/Waf1/Sdi1 nor cyclin D1 induction (Figure 11a-f).
Selected cytoskeletal components - vimentin and G-actin
Cytometric analysis for the percentage of vimentin-
positive cells indicated that there were no statistically
significant changes in this parameter resulting from the
treatment. Median values ranged between 82-86% for all
the concentrations under study and for the control cells,
which allowed us to exclude the possibility that some
fluctuations in fluorescence intensity might have been
caused by an uneven distribution of antibodies (Figure 12a).
On the contrary, mean fluorescence intensity, reflecting
mean intracellular level of vimentin was increased, which
suggests that etoposide acted stimulating on this protein
in A549 cells as compared to the control population
(Figure 12b). The tendency of these alterations was not
homogeneous, as an initial increase at 0.75 and 1.5 μM
concentrations was followed by lower, but still statistically
significantly high values for 3 μM etoposide.
Fluorescence microscopic observations of vimentin
filaments revealed some unique features of their
organization after the treatment of A549 cells with eto-
poside. A well-developed, regular scaffold of subtle, thin
and short filaments was characteristic for the untreated
control population. In these cells, vimentin filaments
formed an evenly distributed cytoplasmic network with
most visible foci located in the perinuclear area
(Figures 13a and 14a). Etoposide not only induced
alterations in the shape and size of cells, but also a het-
erogeneity in the form and cytoplasmic organization of
vimentin intermediate filaments (Figures 13, 14, 15).
Starting from the lowest concentration (0.75 μM etopo-
side), there appeared some enlarged cells presenting
thick vimentin fibers or their aggregates in the peri-
nuclear region, along the main axis of the cell, but also
more evenly distributed in the cytoplasm (Figures 13b,c,
14d,f, 15a,c). Analogous structures were visible in cells
exposed to 1.5 μM etoposide, and featured a fluorescent
Figure 7 a-f Morphological and ultrastructural changes in A549 cells after treatment with etoposide - electron microscopic
examination. a Control cells (x 7 000), b 0.75 μM etoposide (x 5 000), c, d 1.5 μM etoposide (x 4 000), e, f 3 μM etoposide (x 6 000). Progressive
alterations in the nucleus and cytoplasm area are evident. At the highest concentration some cells displayed features of extensive lysis/demolition
of the cellular content, including dispersed chromatin-like structures appearing in the cytoplasm. Results are representative of five
independent experiments.
Figure 8 a-d Immunolocalization of p21Cip1/Waf1/Sdi1 in A549 cells after treatment with etoposide - fluorescence microscopic
examination (p21Cip1/Waf1/Sdi1 indirect labeling, secondary antibody was goat anti-mouse IgG-Alexa Fluor 488W). a Control cells, b 0.75
μM etoposide, c 1.5 μM etoposide, d 3 μM etoposide. Nuclei were counterstained with DAPI. Results are indicative of three independent
experiments. Bar 50 μm.
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Figure 9 a-f Immunolocalization of cyclin D1 in A549 cells after treatment with etoposide - fluorescence microscopic examination
(cyclin D1 indirect labeling, secondary antibody was goat anti-mouse IgG-Alexa Fluor 488W). a Control cells, b 0.75 μM etoposide, c 1.5
μM etoposide, d, e, f 3 μM etoposide. Enhanced fluorescence signal in selected cells and cyclin D1 aggregations indicated (arrows, arrowheads).
Nuclei were counterstained with DAPI. Results are indicative of three independent experiments. Bar 50 μm.
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ever, in the well-developed network of vimentin fila-
ments, some less regularly woven spaces appeared, in
which organelles and other cytoplasmic inclusions could
be located. Populations of multinucleated/large cells
seemed to be increased in number. In these, vimentin
was abundant and formed ring-like structures, especially
around the nucleus (Figures 13, 14 and 15). A faint,Figure 10 a-e Progressive changes in the morphology of nuclei in A5
microscopic evaluation (staining with DAPI). a Cells with regular nuclei,
abnormalities (lobulation, invaginations, buds), c cells with nuclei indicative
features of SAHF formation. Statistically significant differences as compared
P<0.05). Columns - median percentage of cells, bars - interquartile range. Redispersed and locally disappearing fluorescent signal was
indicative of cells with degenerating cytoskeleton, in
which DNA underwent fragmentation or lysis, especially
at 3 μM etoposide (Figures 13i, 14j,l and 15d,f ). At
this concentration, a visible morphological heterogeneity
occurred as well. Apart from the large cells with well-
developed networks of vimentin filaments, some multinu-
cleated cells presenting intense perinuclear fluorescence49 cells after treatment with etoposide - statistical data from
b cells with nuclei of a regular size and with some morphological
of apoptosis (apoptotic bodies), d cells with large nuclei, e cells with
to the control cells are marked by asterisks (Mann–Whitney U statistics,
sults are representative of five independent experiments.
Figure 11 a-f p21Cip1/Waf1/Sdi1 and cyclin D1 are dispersed in the cells with SAHF – fluorescence microscopic examination (staining as
described above). a-c 0.75 μM etoposide, d-f 3 μM etoposide; a, d DAPI, b p21Cip1/Waf1/Sdi1 labeling, e cyclin D1 labeling, c, f merged. Upper bar
25 μm, lower bar 10 μm.
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dispersed signals that reflect more amorphous vimen-
tin structures and lack of a regular filament scaffold
(Figures 13g-i, 14j,l and 15d,f ). Most probably, this
was related to fragmentation of filaments resulting in
the collapse of the cytoskeleton around the nucleus.
An interesting fact worth emphasizing is that after
exposure of A549 cells to etoposide, vimentin was abun-
dantly present in the invaginations of multi-lobulated
nuclei, and especially in the central region of intra-
nuclear space between multiple nuclei in multinucl-
eated cells. In addition, we observed only a very few
cells featuring chromatin condensations that resemble
senescence-like heterochromatin foci. These cells displa-
yed rather subtle and regularly-woven filament scaffolds,Figure 12 a-b Quantity of vimentin protein in the A549
population after treatment with etoposide - statistical data
from flow cytometric analyses. a Percentage of vimentin-positive
cells, b fluorescence intensity reflecting vimentin content. Statistically
significant differences were not observed as compared to the
control cells (Mann–Whitney U statistics, P<0.05). Columns - median
percentage of vimentin-positive cells, bars - interquartile range.
Results are representative of five independent experiments.devoid of the presence of similar aggregating structures in
the perinuclear space (Figure 15).
Both methods employed for G-actin analysis (i.e. with
DNase I and VDBP) suggested a rather uniform loca-
lization of this component in the control A549 cells in
comparison with the etoposide-exposed population, in
which more intense staining was characteristic of the
perinucear region of the cell (Figures 16 and 17). These
alterations were especially evident in large cells posses-
sing segmented nuclei or in multinucleated cells result-
ing from the treatment (Figures 16 b-d and 17 b-d). The
perinuclear foci were similar to ring-like vimentin struc-
tures, but less regularly organized. Some aggregates,
most probably reflecting the process of actin filament
nucleation, were found in the central and cortical parts
of the cytoplasm. Other structures detected via DNase I
labeling, suggest either an increased number of G-actin-
positive vesicles, which may have been formed during
extensive exocytosis/DNA degradation in response to
etoposide, or may simply result from DNase I affinity
to some mitochondrial components, in which case they
reflect oxidative-stress induced formation of these orga-
nelles (Figure 16). Nevertheless, most intense fluorescence
was observed in the cells presenting a cell death phe-
notype defined by the presence of pyknotic or fragmen-
ted nuclei, irrespective of the staining method employed
(Figures 16c,d and 17c,d).
A relative G-actin content in the cell nucleus was esti-
mated after treatment with etoposide as compared to
the untreated cell population. Statistically significant dif-
ferences were not observed, only some minor fluctua-
tions in fluorescence intensity of G-actin appeared as a
result of the treatment. G-actin fluorescence intensity in
Figure 13 a-i Organization of vimentin in A549 cells after treatment with etoposide - fluorescence microscopic examination (vimentin
indirect labeling, secondary antibody was goat anti-mouse IgG-TRITC). a Control cells, b, c 0.75 μM etoposide, d-f 1.5 μM etoposide, g-i 3
μM etoposide. Apart from regularly organized bundles of filaments in the control cells, abundant, but more heterogeneously organized structures
appeared as a result of the treatment. Thick arrows point at dense, thick vimentin bundles in the form of septum-like aggregates between sister
nuclei, especially common in multinucleated cells, or vimentin threads in the nuclear invaginations; double thick arrows - putative budding-like
structures in close proximity of the parental cells; thin arrows - long vimentin tails; arrowheads - diffuse vimentin staining around nuclei with
features of karyorrhexis or karyolysis. Nuclei were counterstained with DAPI. Results are indicative of five independent experiments. Bar 50 μm.
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These indications were further supported by preliminary
confocal microscopic examination.
Discussion
Senescence on the cellular level is believed to be a pro-
gram of irreversible cell cycle arrest, in which the cell
stays unresponsive to mitogenic stimulation. However,
metabolic activity of the cell is retained, resulting in the
appearance of some morphological manifestations that
may be defined as a senescent cell phenotype, and in-
clude enlargement accompanied by flattening of the cell,
enhanced activity of senescence-associated ß-galactosi-
dase, lipofuscin accumulation, as well as increased cyto-
plasmic granularity and nuclear volume. Some further
alterations related to the nucleus and its functionscomprise formation of SAHF and, above all, changes in
the expression pattern of tumor-suppressor genes, e.g.
p53, p21Cip1/Waf1/Sdi1, p14Arf, p16Ink4a, pRb [16-19].
However, on the basis of the results obtained in the
present study, as well as our previous report [20] and
insight gained from experiments of others, we suggest
that there should be a clear distinction between senes-
cence on the cellular level and senescence of the whole
population of cells, e.g. cell line models. The first obser-
vations regarding these phenomena came from the stud-
ies of Hayflick, who presented a restricted proliferative
capacity of cellular populations in vitro [21]. Later, ana-
logical characteristics were shown to exist in cancer cell
lines as a result of chemotherapeutic treatment and
other therapeutic modalities [22-24], although these cells
were previously regarded to be "immortal" due to
Figure 14 a-l Organization of vimentin in A549 cells after treatment with etoposide - fluorescence microscopic examination (vimentin
indirect labeling, secondary antibody was goat anti-mouse IgG-BODIPY). a-c Control cells, d-f 0.75 μM etoposide, g-i 1.5 μM etoposide, j-l 3
μM etoposide; a, d, g, j vimentin labeling, b, e, h, k DAPI, c, f, i, l merged. Staining with this method allow us to visualize in a great detail subtle
threads of vimentin filaments located in the invaginations of nuclei. Apart from regularly organized bundles of filaments in the control cells,
abundant, but more heterogeneously organized structures appeared as a result of the treatment. Thick arrows point at thin threads in the nuclear
invaginations or more dense vimentin bundles in the form of septum-like aggregates between sister nuclei, especially common in multinucleated
cells; double thick arrows - cells presenting long vimentin tails (vimentin staining), closely located sister nuclei or thin chromatin threads
connecting closely located sister nuclei (DAPI); arrowheads - diffuse vimentin staining around nuclei with features of karyorrhexis or karyolysis.
Results are indicative of five independent experiments. Bar 50 μm.
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Moreover, recently the clinical impact of the senescence
program, as well as the pros and cons of its induction
have been broadly discussed [25-28]. At the same time,
the lack of a clear definition and unequivocal markersindicative of this phenomenon, makes it particularly dif-
ficult to firmly establish its contribution to the final
outcome of therapy. All the more so because some fea-
tures are misleadingly perceived as crucial determinants
of the program. These features could include enhanced
Figure 15 a-f Organization of vimentin in A549 cells after treatment with etoposide - fluorescence microscopic examination (vimentin
indirect labeling, secondary antibody was goat anti-mouse IgG-BODIPY). a-c 0.75 μM etoposide, d-f 3 μM etoposide; a, d vimentin labeling,
b, e DAPI, c, f merged. Selected photographs presenting rare nuclei with chromatin structures bearing resemblance to senescence-associated
heterochromatin foci (thin arrows). These cells featured either disappearing (a, c) or more regularly woven (d, f) vimentin scaffold, devoid of
threads/foci typical of nuclear invaginations and/or multinucleated cells. Thick arrows point at septum-like structures between sister nuclei (a, c),
vimentin aggregates in the perinuclear area of multinucleated cells/cells possessing abnormally-shaped nuclei (d, f) or nuclei of these cells (b, e).
Double thick arrows - putative budding-like structures (a, c); arrowheads - diffuse vimentin staining around nuclei with features of karyorrhexis or
karyolysis (d, f). Results are indicative of five independent experiments. Bar 50 μm.
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ploidy induction.
As regards polyploidy induction, it has been documen-
ted that cell population undergoing replicative senes-
cence may feature a defective mitotic checkpoint, which
eventually leads to aberrant mitoses [29]. In view of
these findings, it cannot be ruled out that some nuclear
alterations accompanying polyploidy reflect a crisis-like
event, including some breakage-fusion-bridge cycles that
result in increased genomic instability. In our research,
a G2/M population was increasing in parallel with po-
lyploidy induction, which may rather suggest an endo-
replication-like response after mitotic slippage. At the
same time, the extent of G2/M accumulating cells as well
as SAHF containing cells seemed to be relatively low as
compared to those manifesting enhanced SA ß-galac-
tosidase, a fact which may, along with polyploidization,
suggest an unstable senescence-like program induced
by etoposide. Also results of the TUNEL method imply
an accumulation of cells from G0/G1 and S phases of
the cell cycle into G2/M and transient arrest followed
by some endoreplication/cell death events. Due to the
fact that extensive DNA fragmentation accompanied
these alterations, chromosomal instability and breakage-
fusion-bridge cycles could not be excluded. Similar resultswere obtained by Sliwinska et al. (2009) after treatment of
HCT116 cells with doxorubicin, another topoisomerase II
inhibitor. The authors claimed that a substantial fraction
of the cells underwent endocycling without entering mi-
tosis, and that some dividing polyploid cells produced an-
euploid progeny [30].
DNA damage signaling has been proved to be coupled
to its replication in direct response to topoisomerase
inhibitors, including etoposide in the A549 cell popula-
tion. On the one hand it suggests the induction of DSB
following collision of cleavable complexes with replica-
tion forks, but some DSB also appeared in non-
replicating cells, which may be indicative of other
mechanisms of action of this drug, i.e. oxidative stress
generation or collision of cleavable complexes with tran-
scription machinery [31]. On the other hand, it is tempt-
ing to consider its influence on mitotic cells and the
involvement of the DNA replication process in the long-
term response to etoposide. Our results obtained from
the TUNEL method confirm the findings of Zhao et al.
(2012) regarding the lack of cell-cycle specific effect on
DSB induction. However, in our study, G2/M and poly-
ploid fractions apparently accumulated the highest num-
bers of damaged cells, which may imply some abnormal/
abortive mitoses accompanied by endoreplication-like
Figure 16 a-d Localization of G-actin in A549 cells after treatment with etoposide - fluorescence microscopic examination (labeling
with DNase I). a Control cells, b 0.75 μM etoposide, c 1.5 μM etoposide, d 3 μM etoposide. Visible aggregation of G-actin in the perinuclear area
after the treatment, as well as an increased number of G-actin-positive dot-like and vesicle-like structures in the cytoplasm. The intense
fluorescence patterns indicative of cells with DNA fragmentation. Nuclei were counterstained with DAPI. Results are indicative of five independent
experiments. Bar 50 μm.
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fact that in our investigation, regular mitotic figures
were only observed exceptionally in etoposide-exposed
cells, whereas nuclei presenting atypical morphology
were rather abundant. In addition, the TUNEL-positive
cells were more abundant after treatment in comparison
with the cells presenting biochemical features of cell
death in the annexin V/PI assay. There is clear evidence
that endo-polyploidization in senescent cell popula-
tion constitutes a consequence of re-replication of ge-
nomically-damaged G2/M cells [32]. At the same time,
independent karyoplasts/reproductive genome-reduced
subcells may form from giant polyploid cells via some
kind of reductional division, resulting in increased gen-
etic variation [33,34]. What is more, induction of DNA
damage in cancer cell lines was proven to be related not
only to endopolyploidy and depolyploidization, but also
to overexpression of meiosis-specific genes and mobili-
zation of their products to the sites strategic for division
[35-37]. More recently it has also been reported that al-
though there are some morphological and biochemical
features of senescence as well as growth arrest in the
population of A549 cells exposed to topoisomerase II
inhibitors [20,38], long term effects of the treatment in-
clude a re-growth of a fraction of population originating
most probably from cancer stem cells [38]. In this sit-
uation, a somewhat more prolonged, but still rever-
sible growth arrest of the population occurred after
inhibition of the DNA damage response pathway. Dueto the fact that 24 h after exposure to etoposide we
still observed a relatively high number of TUNEL-positive
cells in comparison with those annexin V/PI-positive, this
pathway was most probably active in our experiment
as well.
Hence, some alterations in heterochromatin features,
like gluey or stick heterochromatin in near-senescent
population of cultured cells, seem to be responsible for
mitotic failure and chromosomal instability [39]. Ana-
logically, etoposide may induce impairments in untan-
gling of chromatin, which in turn interferes with the
proper formation of chromosomes and the decatenation
of chromatids [5], leading most probably to the same
final outcome, i.e. induction of a senescent-like pheno-
type in the cancer cell population along with increased
polyploidy and genetic instability, as well as heterogen-
eity of the response. What is more, an unstable senes-
cence program induced in cancer cell populations by
DNA damage is thought to be related to a phenomenon
corresponding to the above-described series of events,
and termed neosis [40,41]. In fact this process may con-
tribute to chemotherapy resistance, due to the fact that
increased instability along with repeated cycles of self-
renewal may favour the accumulation of survival-
promoting mutations and the expansion of more inva-
sive subclones, especially under continuous contact with
a chemotherapeutic drug [37]. Moreover, polyploidy was
suggested to be a transiently appearing response to treat-
ment, followed by differentiation of the genetic material
Figure 17 a-d Localization of G-actin in A549 cells after treatment with etoposide - fluorescence microscopic examination (labeling
with VDBP). a Control cells, b 0.75 μM etoposide, c 1.5 μM etoposide, d 3 μM etoposide. Visible aggregation of G-actin in the perinuclear area
after the treatment, as well as in the form of dot-like structures in the cytoplasm. The intense fluorescence patterns indicative of cells with DNA
fragmentation. Nuclei were counterstained with DAPI. Results are indicative of five independent experiments. Bar 50 μm.
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autophagic degradation [42].
As regards the second above-mentioned senescence
marker, i.e. senescence-associated ß-galactosidase, the
activity of this enzyme reflects changes in lysosomal
content and functions, and consequently the altered cel-
lular metabolism of aging cells [16,43-45], which does
not interchangeably mean a cell cycle-arrested cell. This
is also supported by our observations of the cell ultra-
structure following the treatment, which revealed abun-
dantly present large lysosomes containing numerous
inclusions of degradable and non-degradable materials
such as lipofuscin, but also some organelles or their
components. However, as an increased lysosomal mass
may also appear in other processes such as, for exam-
ple, autophagy, as evidenced by acridine orange staining
[46], an enhanced activity of this enzyme may be indi-
cative of this kind of metabolic shift as well. Therefore,
senescence-associated ß-galactosidase activity should not
be regarded as the sole marker of the senescence pro-
gram on the cellular level. Moreover, our results showed
an uncoupling between an enhanced activity of this en-
zyme and cell cycle arrest, as the tendencies of these two
parameters seemed not fully consistent. Analogical re-
sults were obtained by Dulić et al. (2000), who reported
a discrepancy between the senescence-like phenotype
and cell cycle block in human diploid fibroblasts trans-
fected with HPV E6 oncogene that contributed to p53
degradation and in p21Cip1/Waf1/Sdi1 nullizygous mouse
embryonic fibroblasts [47]. Thus, being neither a crucialdeterminant nor an unequivocal reflection of stable cell
cycle arrest, an enhanced senescence-associated ß-galac-
tosidase activity rather reflects a metabolic response
of the cell to stress. Nevertheless, it has been recently
reported that autophagy mediates a transition of mi-
totic cells to senescence, especially influencing the phe-
notype, and that autophagic degradation of DNA is
an important factor during segregation of subnuclei
in polyploid cells [42,48]. These suggestions are also
consistent with the particularly high activity of this
enzyme in polyploid A549 cells resulting from the treat-
ment with etoposide observed in this study. What is
more, in our fluorescent microscopic, as well as transmis-
sion electron microscopic analyses, we were able to dis-
tinguish some diffuse DAPI staining, DNase I staining
and some dispersed chromatin-like structures in the cy-
toplasm of A549 cells after treatment. This supports the
hypothesis of DNA degradation. It therefore seems
that an increase in the activity of senescence-associa-
ted ß-galactosidase is particularly related to phenotypic
alterations in the senescent cell population. Morphological
changes typical of a senescence-like response were also
confirmed by our observations at the ultrastructural
level, which was evident from increased heterogeneity
of the cytoplasmic compartment, but also progressive
alterations of the nuclei. The latter were most prob-
ably a phenotypic manifestation of abnormal mitoses/
mitotic catastrophe.
Some hallmarks of the senescence phenomenon strict-
ly related to the execution of a cell cycle arrest are
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regulatory molecules, including cyclin-dependent kinase
inhibitors, cyclin-dependent kinases and cyclins, as well
as formation of SAHF [18,23,25,26,30]. p21Cip1/Waf1/Sdi1
was previously reported to be a reliable marker of pre-
maturely induced senescence in many cancer cell lines.
Particularly, profound alterations in the expression of
the gene encoding this protein and/or in the localization
of its product were observed, which may be the major
contributor to the G2/M arrest, but also may activate the
G1 checkpoint [30,49]. For example, Sliwinska et al.
(2009) found lack of Ki-67 expression along with
increased expression of p21Cip1/Waf1/Sdi1 and cyclin D1 in
HCT116 cells after incubation with a low dose of doxo-
rubicin. As regards their fluorescence microscopic obser-
vations, the large senescent-like cells manifested evident
bright signals for p21Cip1/Waf1/Sdi1 [30]. To refer more
specifically to the A549 population, we would like to
mention the work of Shen and Maki (2010). The authors
documented there that p21Cip1/Waf1/Sdi1 induction and
its nuclear accumulation were indispensable for main-
tenance of a senescence-associated G1 cell cycle arrest of
A549 cells with unreduced DNA content (4N) after tran-
sient Nutilin-3a treatment, with knock-down of p21Cip1/
Waf1/Sdi1 or p53 resulting in endoreduplication [49].
These findings are particularly interesting in light of our
observations, which did not reveal significant changes in
p21Cip1/Waf1/Sdi1, supporting the hypothesis of an un-
stable senscence-like state induction that was accompan-
ied by endocycling events in our conditions. As reported
earlier, insufficient p21Cip1/Waf1/Sdi1 activity in human
fibroblasts with morphological features of a senescence
program may lead to uncoupling between phenotypic
features of the senescence program and cell cycle arrest
[47], in accordance with our results as well. Further evi-
dences also reinforce this point of view, indicating that
in the absence of the proper p21Cip1/Waf1/Sdi1 function,
cells may undergo a transient G2-like arrest, which is
followed by replication without regular intervening mi-
toses [50].
We think that such a compromised senescence phenotype
or senescence-like state may be a consequence of the muta-
tions identified in A549 cells, in particular homozygous dele-
tion of the Ink4b/Arf/Ink4a locus [8-11]. This, in turn, may
render the cells incapable of activation of not only p16Ink4a,
but also p14Arf, which is an upstream regulator of p53-
mediated p21Cip1/Waf1/Sdi1 induction via HDM2 sequestra-
tion. Previous works aimed at elucidation of the functions
that are specifically fulfilled by p16Ink4a and p21Cip1/Waf1/Sdi1
during senescence execution and suggested their comple-
mentation for the most efficient induction and maintenance
of the program [51]. The circumstances vital for the irrever-
sibility of senescence are presently being determined for
both the Rb and p53-mediated pathways, in which theabove-mentioned proteins constitute essential players. These
involve the positive feedback loop of ROS accumulation in
case of p21Cip1/Waf1/Sdi1 and SAHF formation in case of
p16Ink4a -Rb [52,53]. Therefore, in order to verify a potential
contribution of the p16Ink4a -Rb arm that may result in the
G0/G1 arrest, we checked the status of cyclin D1 and SAHF
formation in our study.
In agreement with other reports describing accumula-
tion of cyclin D1 in senescent cells and our results with
the HL-60 cell line (manuscript in preparation), here we
showed some changes in the amount and localization of
this protein in a senescence-like state. Increased cyclin
D1 level is regarded by some authors as a feature of
senescence-like conditions that are accompanied by
polyploidization events [30,54-56]. At the same time, the
major role of this protein is to act as an antagonist of
Rb-mediated cell cycle arrest and to drive the cell cycle
progression through G1 phase [57]. Therefore, it should
not be surprising that an enhanced expression of this
protein may be followed by an unfavorable prognosis,
especially if it is activated during senescence-like condi-
tions [30,56]. Many reports concerning cyclin D1 in sen-
escence, refer in fact to a senescence-like state in the
population of heterogeneous by nature cancer cells. The
recent report of McGowan et al. (2012) clearly demon-
strated the possible latent effects of nuclear accumula-
tion of cyclin D1 in a population of MCF-7 cells
presenting typical senescence-like morphology as a con-
sequence of the 14Arf-p53-p21-Rb pathway activation.
These effects were predominantly related to relocaliza-
tion of Ki-67 into the nucleoli, increased genomic in-
stability and abnormal cell divisions [56]. Such
morphological features and nuclear cyclin D1 accumula-
tion were evident also in our experiment, suggesting,
along with low frequency of SAHF, the instability of the
induced state. As regards nucleolar sequestration of the
cyclin D1 protein observed by us, the phenomenon may
have several alternative implications for senescence exe-
cution, which presently remain obscure. First of all, se-
questration of other cell-cycle regulators contributes to
their inactivation [58]. Bearing in mind the morphology
of the cells that accumulated cyclin D1 and only faint,
dispersed staining in the cells with SAHF, it may also be
hypothesized that sequestration probably serves the spe-
cial purpose of inactivation of the protein on a cellular
route to senescence. However, the phenomenon requires
a more in-depth revision, especially in face of the fact
that mammalian cyclin D1/Cdk4 complexes have been
proven to contribute to endoreduplication, most prob-
ably via the stimulation of nucleoli enlargement and
ribosomal biogenesis [59]. In our study the nuclei of
polyploid cells showed often intense cyclin D1 staining,
sometimes accompanied by intranucleolar aggregations
as well.
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been involved in the execution of a cell cycle arrest, we
would have been able to observe an increased number of
the cells with SAHF manifestation. Derepression of Rb
after inactivation of cyclin D1, may have led to supres-
sion of the E2F target genes crucial for replication and,
finally, to activation of the SAHF pathways essential for
irreversibility of the program. In fact, this was not the
case in our conditions. Instead, we found the cells with
widespread DNA damage and abnormal morphological
features indicative of inappropriate DNA replication and
aberrant proliferation.
In order to gain a more in-depth insight into the state
of A549 cells following exposure to etoposide, we re-
ferred also to analyses of some previously described
cytoskeletal indicators of senescence, i.e. G-actin and
vimentin.
Vimentin is mainly expressed in cells of mesenchymal
origin and has been described as a marker of epithelial-
to-mesenchymal transition, which is a phenomenon
related to increased invasiveness and resistance of some
cancer cells, thus manifesting the progression of cancer
[60,61]. On the other hand, there are studies document-
ing an abundant vimentin presence, as well as its special
role in phenotypic changes that accompany senescence
phase in cell populations [12,15,62].
Here we would like to suggest for the first time a special
role for vimentin in multinucleated dividing cells resulting
from etoposide exposure. Since the protein accumulates es-
pecially in the intranuclear spaces of multinucleated cells
which are expected to give origin to aneuploid progeny, as
well as in invaginations of lobulated nuclei, it is highly prob-
able that it also contributes somehow to the formation, sep-
aration, segregation and isolation of nuclei with reduced
DNA content, which, according to previous reports [33,42],
is followed by the budding of individual karyoplasts/paradi-
ploid descendants from the parental nucleus. Darkly stained
structures were observed by Walen (2005) in the division
furrow during amitotic divisions of polyploid nuclei in a sen-
escent cell population [33]. Our morphological observations
strongly suggest the involvement of vimentin in this process,
because the most intense fluorescence signal was also evi-
dent in division axis between putative daughter nuclei iden-
tified by their aberrant morphology, different sizes and
shapes. In these cells, similar to the study of Walen (2005),
we noticed the presence of some division-like furrows star-
ting from invaginations that were in close proximity to
vimentin-rich areas of the cytoplasm, as well as small
distances between sister nuclei, filled with septum-like vi-
mentin structures, which suggests amitotic divisions. Cyto-
plasmic tails, most probably indicative of the process of
karyoplast budding, were also present in both studies, and
in our case they were shown to be vimentin-rich. Addition-
ally, in our experiment aggregation of this protein wasparticularly evident around multiple nuclei of giant cells,
often at the expense of its distribution in the perpiheral
cytoplasmic areas, which on the whole resembled the
process of vimentin retraction into the form of ring-like
structures. It has previously been shown that vimentin parti-
cipates in cytokinesis, being expressed in a cleavage-furrow
specific manner. Its mutant form, unresponsive to Aurora B
phosphorylation, left daughter cells unseparated [63]. In
light of these findings and our results it seems especially
interesting that giant cancer cells appearing after irradiation
and expressing catalytically active Aurora B kinase, also re-
tain the capacity to divide [64]. Some multinucleated cells
presented by these authors also had features of abnormal
divisions including uneven distribution of chromatin into
daughter nuclei, the presence of thin chromatin threads and
cytoplasmic tails connecting dividing cells. Besides that,
previous studies have indicated that intermediate filaments
are crucial for regulation of germ cell nuclear behaviour,
participating in meiosis, selection of meiotic products, for-
mation of the gametic pronucleus, its transfer across cell-
cell junctions and, finally, in pronuclear fusion during
zygote formation in Tetrahymena [65]. Intermediate
filament-related protein MNS1 is also thought to contrib-
ute to the organization of nuclear morphology during
meiotic prophase [66]. In addition, the activity of the iso-
lated head domain of vimentin, released by HIV-1 prote-
ase, has been shown to be both necessary and sufficient
for alterations of nuclear shape including the formation
of invaginations and extensive lobulation, as well as for
chromatin reorganization [67].
In further agreement with our hypothesis, rare cells
presenting heterochromatin morphology indicative of
SAHF, which may imply more stable cell cycle arrest,
presented quite the opposite vimentin organization, i.e.
rather regular, faintly-woven, occasionally even dispersed
structures. Thus far there have been contradictory indi-
cations related to senescence-associated vimentin regula-
tion, as well as its possible function in the program.
Firstly, overproduction of vimentin is considered to be
indicative of senescence phase in cultured cell popula-
tion [12], however, depending on the tissue or cell type,
its expression may also be diminished [68]. Secondly,
apart from its anti-oncogenic and suppressive functions
during cellular transformation, the possible involvement
of this protein in senescence delay and spontaneous
transformation has been proposed [12,69]. Vimentin is
believed to contribute to recombinational repair of nu-
clear and mitochondrial DNA [69] and, in line with
these observations, this cytoskeletal protein may partici-
pate in cytoplasmic anchorage of p53 during senescence
[15], thus making it unavailable for its transcriptional
targets and, as a consequence, limiting its nuclear-
dependent tumor suppressor functions and downstream
pathways of cell death and/or cell cycle arrest. However,
Litwiniec et al. Cancer Cell International 2013, 13:9 Page 16 of 22
http://www.cancerci.com/content/13/1/9as opposed to senescence, which is considered to be a
tumor-suppressive mechanism, other reports also sug-
gest an involvement of this protein in immortalization
and epithelial-to-mesenchymal transition, both events
related to carcinogenesis and tumor progression. How-
ever this may only be an apparent contradiction, because
a senescent cell population constitutes a source of
extended life cells, participating in transformation to
immortalized ones [33]. What is more, since it is
engaged in extensive repair processes, this protein has
the potential to promote increased plasticity of the gen-
ome and invasiveness of cancer cells [69]. Interestingly,
further evidence of vimentin’s contribution to the integ-
rity and repair of the genome is the fact that the destruc-
tion of this cytoskeletal component during early stages
of apoptosis actually reinforces a pro-apoptotic signaling
cascade in the cell, via the product of its proteolysis
[70-72], thus making it an attractive candidate among
possible „point of no return” sensors. Here we would
like to point out the difference in vimentin organization
between cells with typical manifestations of SAHF, the
multinucleated cells containing abnormally-shaped, ir-
regular nuclei including micronuclei, their putative des-
cendants, as well as the apoptotic cells. Additionally, our
cytometric analyses support indications of an increased
vimentin content in the senescent cell population as a
whole, which may reflect not only a shift in morphology
towards an increased cell volume, but also accumulation
of vimentin in the cytoplasmic areas crucial for the sep-
aration of individual nuclei.
G-actin has previously been described as a marker of
senescence, and further studies revealed that especially
its nuclear accumulation may be correlated with cell
cycle arrest in G1 [13,73]. Nuclear G-actin pool was vis-
ibly increased not only in replicative, but also in stress-
induced premature senescence of human diploid fibro-
blasts, which was also accompanied by alterations in the
expression and distribution of phosphorylated Erk1/2
kinases and small G proteins (belonging to the Rho fam-
ily). These changes have been interpreted as a reflection
of impairments in nuclear export of actin resulting from
improper regulation of MEK signaling pathway [73]. In
turn, subsequent observations have shown that the in-
crease in G-actin pool may also be related to the pres-
ence of cofilin in the nuclei of senescent G1-arrested
fibroblasts, because cofilin appeared there in its active,
dephosphorylated form, capable of F-actin fragmentation
[13]. In support of this, it was also reported that depho-
sphorylated cofilin-dependent nuclear import of actin
occurs in response to stress [74] and that analogical
stress-induced events are regulated independently of
apoptosis [75]. Moreover, there are some indications of
possible interrelations between nuclear actin and prolif-
erative capacities of the cell. These suggest that anenforced G-actin export from the nucleus induced not
only the reversal of phenotypic and biochemical senes-
cence features, but also stimulated cell cycle progression
and replication of previously G1-arrested cells [13]. On
the other hand, impairments in G-actin export were
related to growth arrest and the appearance of senescent
morphology [13,76]. Furthermore, nuclear G-actin accu-
mulation is considered to be an early and universal mar-
ker of senescence in the cell, including senescent cancer
cells [13].
In our study, microscopic quantitative analyses of G-
actin content in the nucleus area did not show signi-
ficant changes after etoposide exposure. However, we
believe that this is consistent with previous reports sug-
gesting that dephosphorylated cofilin is a crucial factor
for nuclear G-actin accumulation and stable G1 cell
cycle arrest. In fact, we observed an increase only in G2/
M population, in which cofilin levels are supposed to be
the lowest. Thus, the lack of nuclear G-actin accumula-
tion in this study further reinforces our assumption that
unreduced G2/M cells were not irreversibly arrested in
G1, but rather underwent endoreplication. However,
some cytoplasmic G-actin alterations were evident and
we suggest they may be caused by several synergistically
acting events, including oxidative stress generation, cell
death induction, exocytosis and changes in the cell
morphology. Oxidative stress is known to influence the
amino acid sequence of actin, via modifications in resi-
dues critical for the process of polymerization [77]. In
accordance with this, and with previous studies docu-
menting dose-dependent depolymerization of F-actin
under the influence of etoposide [78], we observed here
a more prominent cytoplasmic staining for G-actin with
both methods employed. Based only on DNase I label-
ing, we would not have been able to exclude the possi-
bility that this more intense signal had in fact indicated
an enhanced mitochondrial biogenesis and/or autopha-
gic DNA degradation in response to etoposide, as has
previously been suggested [42,79].
The most intense fluorescence of G-actin was docu-
mented in this study for cells presenting apoptotic-like
morphology, including nuclear fragmentation and the
formation of apoptotic bodies, which was most probably
also indicative of F-actin cytoskeleton destruction, but
may also imply an involvement of actin in the develop-
ment of morphological symptoms and/or cell death exe-
cution. For example, it has been shown that actin
filaments aggregate at sites of apoptotic bodies forma-
tion [80]. Apart from that, early stages of apoptosis are
characterized by low expression of actin, subsequently
followed by F-actin reorganization and accumulation of
G-actin in apoptotic bodies [81]. In light of these find-
ings, it also seems meaningful that G-actin functions as
an inhibitor of DNase I [82-84] until the proteolytic
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inhibition of the proteolytic cleavage of actin results in
the suppression of DNA fragmentation in etoposide-
treated cells, and mutation of the cleavage-site may actu-
ally lead to cellular transformation [82,85]. The presence
of actin was shown to be crucial for transduction of
necrosis-related signaling into mitochondria [86].
Conclusions
In conclusion, although the occurrence of a stable senes-
cence program in single etoposide-exposed cells could
not be ruled out, e.g. as a result of mitotic block in cells
with failed cytokinesis [87], a great deal of caution
should be advised when interpreting a general response
to etoposide in A549 cell population as a senescence
phenomenon. In this study, SAHF, which are believed
to contribute to cell-cycle exit via suppression of pro-
liferation-driven genes, were observed only exception-
ally. Moreover, although G2/M arrest occurred, it was
accompanied by a concomitantly increasing fraction of
polyploid TUNEL-positive cells, which, along with the
lack of nuclear G-actin accumulation seems to exclude a
stable G0/G1 arrest of cells with unreduced DNA con-
tent. We suggest that a delicate balance between self-
renewal and senescence in A549 cells may be affected as
a result of impairments in two important senescence
pathways, i.e. via p53 and pRb. This, in turn, may be a
consequence of the genetic background of A549 cell line,
i.e. homozygous deletion of the Ink4b/Arf/Ink4a locus.
In agreement with these presumptions, it has been pre-
viously documented that p53 and/or p16Ink4a defects
may contribute to the proneness of some lung cancer
cells to senescence escape [27]. In our microscopic
observations we were also unable to show significant in-
duction of either p21Waf1/Cip1/Sdi1 or prominent SAFH
formation, supporting the suggestion that some features
of senescence may appear in this situation independently
of a cell cycle arrest and/or secondarily, as a conse-
quence of abnormal mitosis/polyploidization. Aberrant
regulation of cyclin D1 may also contribute to this
phenotype, which requires further studies.
Thus, the response of the A549 population to etopo-
side may be described as heterogeneous, demonstrating
not only some features of cell death, but also broad poly-
ploidization events typical of a pre-senescent stage, as
well as the senescence-like phenotype manifesting itself
mainly as a kind of metabolic shift, resembling autopha-
gic demolition of the cellular content. This seems par-
ticularly interesting in light of recent findings suggesting
the involvement of autophagy in the development of
morphological symptoms at a pre-senescence stage
[42,48,88,89], but the precise role of this program is yet
to be determined. Besides that, pre-senescent tetraploid/
polyploid cells were shown to coordinate DNA-damageresponse, self-renewal and senescence signalling path-
ways [42,90,91], constituting a potential source of
extended-life cells or, in cancer cell populations, cancer
stem cells [37,38]. Apart from that, the morphological
senescence-like alterations observed by us were un-
accompanied by a stable cell cycle arrest.
Last but not least, here we present preliminary mor-
phological evidence for the possible role of vimentin in
depolyploidization of giant cancer cells appearing as a
result of a pre-senescent stage induction.
Methods
Cell culture
A549 cells were grown in monolayer in Dulbecco's
modified Eagle's medium with Glutamax (DMEM;
Gibco) with 50 μg/ml gentamycine (Sigma-Aldrich) and
supplemented with fetal bovine serum (FBS; Gibco) at a
final concentration of 10%. Cell cultures were main-
tained at 37°C in a humidified CO2 incubator.
Etoposide (SintopozidW) was obtained from S.C. SIN-
DAN S.R.L., Bucharest, Romania. The drug was kept in
accordance with the supplier's recommendations, and
working solutions were prepared in fresh medium prior
to use. Cells in the exponential phase of growth, 24 h
after seeding, were incubated with increasing concentra-
tions of etoposide (0; 0.75; 1.5; 3 μM) for 72 h. Before
further experimental procedures, the cells were cultured
for an additional 24 h in a fresh drug-free medium.
Senescence-associated ß-galactosidase assay
Senescence-associated ß-galactosidase activity was deter-
mined using the Senescent Cells Staining Kit (Sigma-
Aldrich), in accordance with the enclosed instructions.
After rinsing with Dulbecco's PBS, the cells were fixed on
coverslips with a solution containing 2% formaldehyde/
0,2% glutaraldehyde for 6 min at room temperature. After
being washed in DPBS, the cells were stained with a
freshly prepared solution (pH 6) including X-gal (5-
bromo-4-chloro-3-indolyl-ß-galactopyranoside) in the
dark at 37°C for 20 h. After that, the coverslips were
rinsed again and mounted with Aqua Poly/Mount
(Polysciences).
The percentage of cells displaying a visible reaction in
the presence of indigogenic substrate was established
microscopically (Eclipse E800, Nikon), and was pre-
sented as the mean value from five fields for each ex-
perimental condition, from at least ten independent
repeats.
Cell cycle analysis
Cells growing on 6-well plates, after trypsinization and
washing, were suspended in PBS (1–2 × 106 cells/ml).
The cell pellet obtained from centrifugation of suspen-
sions (5 min, 300 × g) was resuspended in 1 ml of NSS
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citrate (Sigma-Aldrich) and 0.03% (v/v) nonylphenyl-
polyethylene glycol (Nonidet P40 Substitute; Fluka). Fol-
lowing centrifugation (5 min, 300 × g), the cells were
resuspended in 250 μl of NSS and stained at room
temperature in the dark for 15 min. Finally, each sam-
ple was incubated with 250 μl of RNase A solution
(at a concentration of 10 μg/ml in PBS) (Sigma-
Aldrich) for 15 min at room temperature in the dark.
After the addition of 0.5 ml of PBS, flow cytometric
analysis was performed on a FACScan flow cytometer
(Becton-Dickinson). Cell cycle distribution was esti-
mated for 20 000 events using CellQuest software
(Becton-Dickinson). The whole cell population was divi-
ded into fractions with respective DNA contents (G0/G1;
S; G2/M; <G1; >G2).TUNEL assay
A commercially available kit (APO-DIRECT, BD Biosciences
Pharmingen) was used to perform the terminal deoxynu-
cleotidyl transferase-mediated dUTP nick-end labeling
(TUNEL) method analysis to assess DNA fragmentation
rate. Following trypsinization, cells were fixed with 1% (w/v)
formaldehyde (Polysciences) in PBS, 15 min, on ice and then
washed with PBS. Before staining, the cells were resus-
pended in 70% (v/v) ice-cold ethanol (POCh) and kept at
-20°C for at least 18 h. After fixation and permeabilization,
the cells were incubated with staining mixture containing
TdT enzyme and substrate (dUTP-FITC) at 37°C. Counter-
staining was performed with PI/RNase solution. Finally, the
cells were analyzed on FACScan using CellQuest software
(Becton-Dickinson). 20 000 events were acquired and non-
clumped cells were gated.Annexin V assay
The extent of apoptotic and necrotic cell death was eval-
uated based on double staining with annexin V-FITC
and PI using the Annexin V-FITC Apoptosis Detection
Kit (BD Biosciences Pharmingen). The procedure was
performed according to the enclosed protocol. Briefly,
after trypsinization and washing of the cells with PBS,
they were resuspended in annexin V binding buffer in-
cluding 2.5% annexin V-FITC (v/v) for a 15-min incuba-
tion (dark, RT). After centrifugation (5 min, 300 × g),
annexin V binding buffer with 5% addition of PI was
incubated with the resulting pellet for 5 min in the
above-mentioned conditions. Finally, flow cytometric ana-
lysis (FACScan, CellQuest software; Becton-Dickinson)
allowed us to determine the percentages of cells present-
ing biochemical features of early apoptosis (annexin V-
positive/PI-negative), late apoptosis (annexin V-positive/
PI-positive), necrosis (annexin V-negative/PI-positive), as
well as viable cells (annexin V-negative/PI-negative).Immunofluorescence
Vimentin labeling
Cells grown on coverslips in 12-well plates were immu-
nolabeled according to previously published protocols
[92]. The cells were prefixed (10 min, 37°C) with 0.4
mg/ml bifunctional protein crosslinking reagent DTSP
in HBSS [DTSP, 3,3’-dithio-bis(propionic acid N-hydro-
xysuccinimide ester); Hank’s balanced salt solution,
Sigma-Aldrich] and preextracted in Tsb [0.5% (w/v) Tri-
ton X-100 (Serva) in MTSB] containing 0.4 mg/ml
DTSP for 10 min at 37°C, were further extracted in Tsb
(5 min, 37°C) and fixed with 4% (w/v) paraformaldehyde
(Sevra) in MTSB (15 min, 37°C). After incubation with
0.1 M glycine, the cells were blocked with 1% (w/v) bo-
vine serum albumin (both from Sigma-Aldrich) in Tris-
buffered saline, pH 7.6 (BSA-TBS), 2 × 5 min. Mouse
monoclonal anti-vimentin antibody (clone V9; Sigma-
Aldrich) in BSA-TBS (1:200) was used for a 45-min in-
cubation at 37°C in a moist chamber. After being rinsed
thoroughly with BSA-TBS (3 × 5 min), the cells were incu-
bated with goat anti-mouse IgG-TRITC (Sigma-Aldrich)
(1:85) or goat anti-mouse IgG-BODIPY (Molecular Probes)
in BSA-TBS (1:200) in the same conditions. After washing
with BSA-TBS and PBS, the coverslips were counter-
stained with DAPI (diaminophenyl indole; Sigma-Aldrich),
washed 3 × 5 min with PBS and, finally, mounted with
Aqua Poly/Mount (Polysciences).
G-actin labeling
G-actin fluorescent staining was performed according to
two protocols, i.e. using DNase I and vitamin D-binding
protein.
In the first case, permeabilization and fixation steps
were identical to those described for vimentin staining.
After incubation with 0.1 M glycine in DPBS (5 min,
RT) and washing with DPBS (2 × 5 min), the cells were
incubated with 2 μM phalloidin (Sigma-Aldrich) in
DPBS and, subsequently, with DNase I conjugated to
Alexa Fluor 488 (Molecular Probes) in DPBS (1:50, 20
min, in the dark). The coverslips were then washed with
PBS, stained with DAPI, washed again (3 × 5 min) and
mounted on glass slides with Aqua Poly/Mount
(Polysciences).
In the second of the above-mentioned methods for in-
direct staining of non-filamentous actin, previously
described procedures were employed, with some slight
modifications [93-95]. Coverslips were washed with PBS
and fixed with 3.7% (w/v) paraformaldehyde (Serva) in
PBS (20 min, RT). Following washing with PBS (3 × 5
min), a 10-min incubation (RT) in PBS with the addition
of 1 mg/ml NaBH4 (Sigma-Aldrich) was performed in
order to reduce free aldehyde groups. Then, the cells
were rinsed in PBS (3 × 5 min), extracted in 0.1% (w/v)
Triton X-100 in PBS, and further incubated with PBS-
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for 10 min. Incubation steps aiming at G-actin
visualization were as follows: 10 μg/ml vitamin D-
binding protein (DBP, Calbiochem) in PBS-TB (60 min,
RT), goat polyclonal anti-DBP IgG (Santa Cruz Biotech-
nology) in PBS-TB (1:50, 60 min, RT), Alexa Fluor 488-
conjugated donkey anti-goat IgG (Molecular Probes;
1:100, 60 min, 37°C in a moist chamber). All these in-
cubations were split and followed by rinsing in PBS-TB,
3 × 5 min. Finally, the coverslips were washed twice with
PBS, counterstained with DAPI, washed with PBS (3 × 5
min) and subsequently mounted with Aqua Poly/Mount
(Polysciences).
Cyclin D1 labeling
Cells were briefly washed with PBS, fixed in 4% parafor-
maldehyde (15 min, RT) and then washed with PBS (3 ×
5 min). After that, the cells were incubated in
permeabilization solution (0.1% Triton X-100 in PBS, 5
min) and blocked with 1% BSA (30 min). Then, an incu-
bation with mouse monoclonal cyclin D1 antibody
(Sigma-Aldrich) (60 min, RT, moist chamber) followed,
the cells were washed three times with PBS and incu-
bated with Alexa Fluor 488W goat anti-mouse IgG (Mo-
lecular Probes) (45 min, RT). Nuclear staining was
performed using DAPI (Sigma-Aldrich). Finally, the cells
were washed with PBS and mounted on slides in Aqua
Poly/Mount (Polysciences).
p21Waf1/Cip1/Sdi1labeling
The procedure of prefixation, fixation and blocking was
like in the above-described protocol for vimentin. Incu-
bation with mouse monoclonal anti-p21 antibody (sc-
817; Santa Cruz Biotechnology) in BSA-TBS (1:100) was
performed in a moist chamber for 60 min, RT. Then the
slides were rinsed with BSA-TBS (3 × 5 min) and incu-
bated with a secondary antibody (Alexa FluorW 488 goat
anti-mouse IgG conjugate from Molecular Probes) in
BSA-TBS (1:100) in the same conditions. The final steps
were also as described above.
SAHF determination and nuclear morphology evaluation
The estimation of SAHF foci formation was performed
by counting the DAPI-stained nuclei with the typically
distinguished morphology of clearly separated condensa-
tions, enclosed within intact nuclear envelope (micro-
scopic observations). For each sample/concentration, at
least 500 cells were taken into account for each repeat of
the experiment. Other morphological features were also
considered for the quantification of nuclear changes
after the treatment: the cells with enlarged nuclei, the
cells with apoptotic bodies, the cells with nuclei of a
regular size but presenting abnormal morphology and
the cells with regular nuclei.An Eclipse E800 microscope and NIS Elements AR
imaging software (both from Nikon) were employed to
obtain and analyze documentation.
Flow cytometric analysis of intracellular vimentin
Cells grown on 6-well plates were trypsinized, washed
with PBS, centrifuged (5 min, 300 × g) and suspended at
a final concentration of 1–2 × 106 cells/ml in 1 ml PBS
supplemented with 100 μl of formaldehyde (Poly-
sciences). Samples were incubated for 15 min in the dark
and centrifuged (5 min, 300 × g), the resulting pellet was
subsequently permeabilized in 2 ml of ice-cold 50% (v/v)
methanol (JT Baker). After a 15-min incubation on ice,
the cells were washed twice with cold PBS and resus-
pended in 100 μl of PBS. The cell suspensions were then
transferred into flow cytometric tubes containing 20 μl
of PE-conjugated mouse monoclonal anti-vimentin IgG1
(clone V9), or normal mouse IgG1-PE as an isotype con-
trol (Santa Cruz Biotechnology). After a 30-min incuba-
tion on ice, the cells were washed with PBS, centrifuged
for 5 min at 500 × g to remove residues of antibody, and
resuspended in 200 μl of PBS for flow cytometric ana-
lysis on FACScan (Becton-Dickinson). The percentage of
vimentin-positive cells, as well as the mean fluorescence
intensity of the cell population was established using
CellQuest software (Becton-Dickinson).
Quantitative immunofluorescence for nuclear G-actin
measurements
In order to prevent contamination by cytoplasmic actin,
nuclear G-actin was analyzed after isolation of nuclei.
Following trypsinization, washing with PBS and centrifu-
gation (5 min, 300xg), 2 ml of homogenizing buffer [50
mM Tris–HCl, pH 7.5; 0.3 M sucrose; 15 mM CaCl2; 25
mM MgCl2; 10 mM 2-mercaptoethanol (all from Sigma-
Aldrich); 0.5% (v/v) Nonidet P40 Substitute] were added
to each sample. After homogenization on ice, the sus-
pensions were centrifuged (10 min, 1000 × g) and the
supernatant was decanted. The pellet was suspended in
1 ml of homogenizing buffer and gently stratified on top
of the buffer for nuclei purification [10 mM Tris–HCl;
0.3 M sucrose; 25 mM MgCl2; 25 mM KCl; 10 mM 2-
mercaptoethanol (all from Sigma-Aldrich); 41% (v/v) gly-
cerol (Roth)] in fresh tubes (8 ml). The nuclei obtained
by centrifugation (10 min, 1000xg) were washed with
PBS, fixed in 3.7% (w/v) paraformaldehyde (Sevra), and
finally cytocentrifuged on glass slides. Fluorescent stain-
ing was performed with vitamin D-binding protein
according to the above-mentioned procedure. Digital
images from fluorescence microscopy (Eclipse E800;
Nikon) were imported to ImageJ software (National
Institutes of Health) and converted to grayscale (8-bit).
G-actin fluorescence was colocalized with DAPI and
subtraction by the nucleus area was performed. Mean
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value, which is the average grey value for all pixels
within the indicated area.Transmission electron microscopy (TEM)
In order to perform an ultrastructural analysis, cells
grown on 6-well plates were trypsinized and fixed with
2.5% (v/v) glutaraldehyde (Merck) in 0.1 M sodium
cacodylate (Fluka), pH 7.4 for 30 min at RT. Following
washing in cacodylate buffer, the addition of bovine
thrombin (Biomed) and fibrinogen (Fluka) resulted in fi-
brin clot formation, in which cells were entrapped. Then,
the samples were postfixed with 2% (w/v) OsO4 (Serva)
in 0.1 M cacodylate buffer for 1 h at room temperature,
passed through a series of ethanol and acetone solutions,
and finally embedded in Epon 812 (Roth). Ultrathin sec-
tions were prepared, stained with uranyl acetate/lead cit-
rate (Fluka) and examined with a transmission electron
microscope (JEM-100CX; JEOL).Statistical analysis
Statistical software packages (StatSoft, Tulsa, OK;
GraphPad Prism, San Diego, CA) were employed for our
analyses. The results obtained were compared using the
following tests: the non-parametric Mann–Whitney U
test, the Duncan test (for more than 10 repeats, homo-
geneous variance), as well as the Cochran–Cox test (for
non-homogeneous variance). Statistical significance was
determined at P<0.05, unless otherwise stated.
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